NPM1-ALK and FOXM1-dependent CCNB1 gene expression

Stable Identifier
R-HSA-9851092
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Expression of CCNB1, a known FOXM1 transcriptional target, is upregulated in NPM1-ALK+ ALCL cells in a NPM1-ALK and FOXM1-dependent manner (Haque et al, 2019; Leung et al, 2001). FOXM1 binds to a consensus sequence in the CCNB1 promoter as assessed by chromatin immunoprecipitation (ChIP), and knockdown of FOXM1 abrogates CCNB1 expression in NPM1-ALK+ cells. Expression of CCNB1 and other FOXM1 targets contributes to cell growth and colony formation in NPM1-ALK cell lines (Haque et al, 2019).
Literature References
PubMed ID Title Journal Year
11682060 Over-expression of FoxM1 stimulates cyclin B1 expression

Ching, JC, Tsang, AC, Leung, TW, Yao, KM, Tong, CS, Lin, SS, Leung, WY, Wong, GG, Gimlich, R

FEBS Lett 2001
31390744 NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma

Wang, P, Haque, M, Turner, SD, Barger, CJ, Huang, YH, Chen, W, Almowaled, M, Karpf, AR, Lai, R, Li, J

Cancers (Basel) 2019
Participants
Participates
This event is regulated
Disease
Name Identifier Synonyms
anaplastic large cell lymphoma DOID:0050744
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created
Cite Us!